|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 2型糖尿病患者个体化血糖控制目标和药物治疗显示文摘'有效管理糖尿病全球合作组织'(下称'糖尿病全球合作组织')成立的宗旨是为临床提供实用指南以改善糖尿病患者的预后,制定并修改相关策略以改善T2DM患者血糖控制情况。糖尿病全球合作组织提倡对糖尿病患者实行个体化治疗方案,明确需要特殊考虑T2DM患者亚组人群。这篇文章基于此前发表的文献,扩大了实用指南的范围,包括有并发症的新诊断T2DM患者和妊娠期糖尿病(GDM)患者。良好血糖控制是T2DM管理的基石,在预防或延缓糖尿病并发症的发生、发展过程中发挥重要作用。个体化治疗目标和安全及时的血糖达标治疗方案至关重要。另外,还需制定更全面的护理计划以降低心血管风险和改善患者预后。 | 张晓梅 纪立农 Bailey CJ Aschner P Stefano Del Prato LaSalle J JI Li-nong Matthaei S | 2014 | 中国糖尿病杂志2014，22，10： | 16 |
| 2 | β-actin-an unsuitable internal control for RT- PCR显示文摘 | SELVEY S THOMPSON E W MATTHAEI K | 2001 | Molecular and Cellular Probes2001，15，5： | 1 |
| 3 | Pancreatic incidentalomas , a growing clinical challenge exemplified by an intrapancreatic accessory spleen显示文摘 | Matthaei H Schmelzle M Braunstein S | | Wien Klin Wochenschr0，123，56： | 1 |
| 4 | A randomized clinical trial comparing breakfast,dinner,or bedtime administration of insulin glargine in patients with type 1 diabetes显示文摘 | Humann A Matthaei S Roask C | 2003 | Diabetes Care2003，26，： | 1 |
| 5 | A randomized,clinical trial comparing breakfast,dinner,or bedtime administration of insulin glargine inpatients with type 1 diabetes显示文摘 | Hamann A Matthaei S Rosak C | 2003 | Diabetes Care2003，26，6： | 1 |
| 6 | In vivo metformin treatment ameliorated insulin resistance:evidence for potentiation of insulin-induced tranlocation and increased functional activity of glucose transponters in obese(Fa/Fa)Zncker rat adipocytes显示文摘 | Matthaei S Reibold JP Haann A | 1993 | Endocrinology1993，133，7： | 1 |
| 7 | A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes 显示文摘 | Hamann A Matthaei S Rosak C | 2003 | Diabetes Care2003，26，6： | 1 |
| 8 | Pancreatic incidentalomas: a gro- wing clinical challenge exemplified by an intrapancreatic accessory spleen显示文摘 | Matthaei H Schmelzle M Braunstein S | 2011 | Wien Kiln Wochenschr2011，123，56： | 1 |
| 9 | A randomized clinical trical comparing breakfast, dinner, or bedtiome administration of insulin glargine in patients with type 1显示文摘 | Hamann A Matthaei S Rosak C | 2003 | Diabetes Care2003，26，6： | 1 |
| 10 | A randomized clinical trical comparing breakfast dinner or bedtime administration of insulin glargine in patients with type 1显示文摘 | Hamann A Matthaei S Rosak C | 2003 | Diabetes Care2003，26，6： | 1 |
| 11 | Beta-actin- an un- suitable internal control for RT-PCR 显示文摘 | Selvey S Thompson EW Matthaei K et ol | 2001 | Mol Cell Probes2001，15，5： | 1 |
| 12 | In vivo metformin treatment ameliorates insulin resistance: evidence for potentiation of insulin-induced translocation and increased functional activity of glucose transporters in obese (fa/fa) Zucker ratadipocytes显示文摘 | Matthaei S Reibold JP Hammnn A | 1993 | Endcrinology1993，133，1： | 1 |
| 13 | Dapagliflozin improves glycemic control and reduces body weight as add-on therapy to mefformin plus sulfonylurea: a 24-week randomized, double-blind clinical triM显示文摘 | Matthaei S Bowering K Rohwedder K | 2015 | Diabetes Care2015，38，3： | 1 |
| 14 | Effect of in vivo thyroid hormone status on insulin signalling and GLUT1 and GLUT4 glucose transport systems in rat adipocytes显示文摘 | Matthaei S Trost B Hamann A | 1995 | J Endocrinol1995，144，2： | 1 |
| 15 | A randomized clinical trial comparing breakfast,dinner,or bedtime administration of insulin glargine in patients with type 1 diabetes显示文摘 | Hamann A Matthaei S Rosak C | | 0，，06： | 1 |
| 16 | β-Actin an unsuitable internal control for RT-PCR 显示文摘 | Selvey S Thompson E W Matthaei K | 2001 | Molecular and Cellular Probes2001，15，5： | 1 |
| 17 | A randomized clincal trial comparing breakfast, dinner,or bedtime administration of insulin glargine in patients with type 1 diabetes 显示文摘 | Humann A Matthaei S Rosak C | 2003 | Diabetes Care2003，26，6： | 1 |
| 18 | Beta-actin-an unsuitable internal control for RT-PCR显示文摘 | Selvey S Thompson E W Matthaei K | 2001 | Mol Cell Probes2001，15，5： | 1 |
| 19 | Using exenatide twice daily or insulin in clinical practice: results from CHOICE显示文摘 | Mathieu C Ostenson CG Matthaei S | 2013 | Diabetes Ther2013，4，2： | 1 |
| 20 | Pathophysiology and pharmacological treatment of insulin resistance显示文摘 | Matthaei S Stumvoll M Kellerer M | 2000 | En-docr Rev2000，21，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员